title: Case of vancomycin-resistant Enterococcus faecium infection associated with a transjugular intrahepatic portosystemic shunt that was treated with quinupristin/dalfopristin after bacteremia persisted with alatrofloxacin therapy.
authors.affiliation: Department of Medicine, Coney Island Hospital and State University of New York Health Science Center at Brooklyn, 11235, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: Zaman
authors.forename: R
authors.initials: R
authors.lastname: Recco
authors.forename: U
authors.initials: U
authors.lastname: Tejwani
authors.forename: T J
authors.initials: TJ
authors.lastname: Scuto
authors.forename: S
authors.initials: S
authors.lastname: Ahmed
authors.forename: A
authors.initials: A
authors.lastname: Hypolite
authors.forename: G
authors.initials: G
authors.lastname: Jayaraman
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy*; D016984:Enterococcus faecium / Q000187:drug effects*; D024841:Fluoroquinolones; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000009:adverse effects*; D020713:Vancomycin Resistance; D014769:Virginiamycin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D014769:Virginiamycin; C062940:quinupristin-dalfopristin; C106856:alatrofloxacin